300 related articles for article (PubMed ID: 17034137)
1. Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis.
He X; Alian A; Stroud R; Ortiz de Montellano PR
J Med Chem; 2006 Oct; 49(21):6308-23. PubMed ID: 17034137
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides.
He X; Alian A; Ortiz de Montellano PR
Bioorg Med Chem; 2007 Nov; 15(21):6649-58. PubMed ID: 17723305
[TBL] [Abstract][Full Text] [Related]
3. CoMFA based de novo design of pyrrolidine carboxamides as inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis.
Kumar A; Siddiqi MI
J Mol Model; 2008 Oct; 14(10):923-35. PubMed ID: 18626672
[TBL] [Abstract][Full Text] [Related]
4. Tryptanthrin Analogues as Inhibitors of Enoyl-acyl Carrier Protein Reductase: Activity against Mycobacterium tuberculosis, Toxicity, Modeling of Enzyme Binding.
Duca G; Pogrebnoi S; Boldescu V; Aksakal F; Uncu A; Valica V; Uncu L; Negres S; Nicolescu F; Macaev F
Curr Top Med Chem; 2019; 19(8):609-619. PubMed ID: 30834838
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
Subba Rao G; Vijayakrishnan R; Kumar M
Chem Biol Drug Des; 2008 Nov; 72(5):444-9. PubMed ID: 19012578
[TBL] [Abstract][Full Text] [Related]
6. Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations.
Stigliani JL; Bernardes-Génisson V; Bernadou J; Pratviel G
Org Biomol Chem; 2012 Aug; 10(31):6341-9. PubMed ID: 22751934
[TBL] [Abstract][Full Text] [Related]
7. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
Matviiuk T; Rodriguez F; Saffon N; Mallet-Ladeira S; Gorichko M; de Jesus Lopes Ribeiro AL; Pasca MR; Lherbet C; Voitenko Z; Baltas M
Eur J Med Chem; 2013; 70():37-48. PubMed ID: 24140915
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery.
Prasad MS; Bhole RP; Khedekar PB; Chikhale RV
Bioorg Chem; 2021 Oct; 115():105242. PubMed ID: 34392175
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents.
Kamal A; Reddy BV; Sridevi B; Ravikumar A; Venkateswarlu A; Sravanthi G; Sridevi JP; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2015 Sep; 25(18):3867-72. PubMed ID: 26253635
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis.
Inturi B; Pujar GV; Purohit MN
Arch Pharm (Weinheim); 2016 Nov; 349(11):817-826. PubMed ID: 27775177
[TBL] [Abstract][Full Text] [Related]
11. Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening.
Lu XY; Chen YD; Jiang YJ; You QD
Eur J Med Chem; 2009 Sep; 44(9):3718-30. PubMed ID: 19428156
[TBL] [Abstract][Full Text] [Related]
12. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum.
Owono Owono LC; Ntie-Kang F; Keita M; Megnassan E; Frecer V; Miertus S
Mol Inform; 2015 May; 34(5):292-307. PubMed ID: 27490275
[TBL] [Abstract][Full Text] [Related]
13. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
[TBL] [Abstract][Full Text] [Related]
14. N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity.
Guardia A; Gulten G; Fernandez R; Gómez J; Wang F; Convery M; Blanco D; Martínez M; Pérez-Herrán E; Alonso M; Ortega F; Rullás J; Calvo D; Mata L; Young R; Sacchettini JC; Mendoza-Losana A; Remuiñán M; Ballell Pages L; Castro-Pichel J
ChemMedChem; 2016 Apr; 11(7):687-701. PubMed ID: 26934341
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade.
Holas O; Ondrejcek P; Dolezal M
J Enzyme Inhib Med Chem; 2015; 30(4):629-48. PubMed ID: 25383419
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis.
Matviiuk T; Mori G; Lherbet C; Rodriguez F; Pasca MR; Gorichko M; Guidetti B; Voitenko Z; Baltas M
Eur J Med Chem; 2014 Jan; 71():46-52. PubMed ID: 24269516
[TBL] [Abstract][Full Text] [Related]
17. Discovery of New and Potent InhA Inhibitors as Antituberculosis Agents: Structure-Based Virtual Screening Validated by Biological Assays and X-ray Crystallography.
Kamsri P; Hanwarinroj C; Phusi N; Pornprom T; Chayajarus K; Punkvang A; Suttipanta N; Srimanote P; Suttisintong K; Songsiriritthigul C; Saparpakorn P; Hannongbua S; Rattanabunyong S; Seetaha S; Choowongkomon K; Sureram S; Kittakoop P; Hongmanee P; Santanirand P; Chen Z; Zhu W; Blood RA; Takebayashi Y; Hinchliffe P; Mulholland AJ; Spencer J; Pungpo P
J Chem Inf Model; 2020 Jan; 60(1):226-234. PubMed ID: 31820972
[TBL] [Abstract][Full Text] [Related]
18. Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data.
Kuo MR; Morbidoni HR; Alland D; Sneddon SF; Gourlie BB; Staveski MM; Leonard M; Gregory JS; Janjigian AD; Yee C; Musser JM; Kreiswirth B; Iwamoto H; Perozzo R; Jacobs WR; Sacchettini JC; Fidock DA
J Biol Chem; 2003 Jun; 278(23):20851-9. PubMed ID: 12606558
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the inhibitory activity of (aza)isoindolinone-type compounds: toward in vitro InhA action, Mycobacterium tuberculosis growth and mycolic acid biosynthesis.
Chollet A; Stigliani JL; Pasca MR; Mori G; Lherbet C; Constant P; Quémard A; Bernadou J; Pratviel G; Bernardes-Génisson V
Chem Biol Drug Des; 2016 Nov; 88(5):740-755. PubMed ID: 27301022
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel antitubercular compounds through hybrid virtual screening approach.
Muddassar M; Jang JW; Hong SK; Cho YS; Kim EE; Keum KC; Oh T; Cho SN; Pae AN
Bioorg Med Chem; 2010 Sep; 18(18):6914-21. PubMed ID: 20727773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
